Upload
danganh
View
215
Download
1
Embed Size (px)
Citation preview
@cphiww #cphiasean
Organised By:
Safe Water Gives Life Help CPhI support Global Angels: www.cphi.com/angels
6-8 April 2016 • Jakarta International Expo • Indonesia
01 Pharmaceutical market growth in Southeast Asia is projected to reach USD 23 billion in 2015, with average annual growth of 9.6%. In Indonesia, the region’s largest economy, annual growth is over 10% and the market is estimated to be USD 7.1 billion in 2015.
Governments across Southeast Asia are introducing universal healthcare programs. This is driving rising demand for all categories of medicines, especially generic drugs. Since launching its mandatory healthcare coverage program (JKN) in 2014, Indonesia’s government healthcare spending has increased by 4%, and is forecast to reach USD 7.8 billion in 2016.
02
Implementation of the ASEAN Economic Community (AEC) by the end of 2015 will open up greater opportunities for trade and commerce among its member states. Healthcare, including pharmaceuticals, has been identified as a key sector where efforts to achieve harmonization of laws and standards will be concentrated.
03
Indonesia has eased investment rules, allowing foreign ownership of up to 85% in the pharmaceutical sector, and is encouraging further investment growth in this sector.
04
CPhI South East Asia and its co-located events InnoPack and P-MEC provide the perfect platform to connect with and do business in the pharmaceutical industry of the Southeast Asia region
International Exhibitor Contact: Francis Onochie E. [email protected] T. +31 (0)20 40 99 529
South East Asia Exhibitor Contact: Maria Lioe E. [email protected] T. +62 21 2930 5959
Indonesia imports over 90% of the pharmaceutical ingredients it uses. The value of imports during the first half of 2015 saw a staggering rise of 17%, to USD 296 million.
05
Book Your Stand
Indonesia – Your Gateway to South East Asia’s Pharma Market
3 Pharma Events under 1 roofCPhI, P-MEC & InnoPack South East Asia -The 3 most important sectors of pharma manufacturing:ingredients, machinery & equipment and packaging.
The marketplace for pharma ingredients manufacturers, suppliers and buyers.
Showcases the newest pharma machinery, equipment and technology.
Brings the latest innovations in packaging and drug delivery systems.
Visitors Statistics
Visitor’s Product Main Areas of Interest
Visitors of top pharma companies that attended Abbot Indonesia, Actavis Indonesia, Bayer, Boehringer Ingelheim, Dankos, Darya Varia, GlaxoSmithKline, Indofarma, Pfizer and more...
http://www.cphi.com/asean
CPhI South East Asia Forum - Over 50 tracks covering the latest topics in the pharmaceutical industry will be presented at the forum by industry experts
Innovation Gallery - Showcasing the most innovative and revolutionary products within pharma
Business Matchmaking Program - Free service to pre-arrange meetings with buyers and suppliers to optimize your time.
CPhI South East Asia: over 6,000 attendees meeting more than 260 exhibitors from 31 countries
P-MEC Route - Daily tour guiding visitors to exhibitors who showcase pharmaceutical machineries and technologies
Health ingredients (Hi) South East Asia - This is an exciting new addition to the region’s most comprehensive pharmaceutical event. Health ingredients (Hi) South East Asia focuses on the health, functional and natural ingredients that are used in pharmaceuticals, health products, foods and cosmetics.
Visitors’ top job positions
Visitors by country (outside Indonesia)
Hong KongKorea
ChinaJapan
MalaysiaThailand
IndiaVietnam
SingaporePhilippines
30%QA & QC
23%
DepartmentHead
7%R&D
12%
Scientist, Chemist,Pharmacist
5%
BusinessDevelopment
16%
SeniorManagement
API’s, 16%
Pharmaceutical Packaging, 10%
Excipients/Formulation, 9%
Finished Formulation, 9%
Pharmaceutical Technology, Laboratory and Analytical
Equipment, 9%
Biopharmaceuticals, 8%
Natural Extract, 7%Analytical & Lab Services, 6%Bio Services, 5%
Contract Services, 5 %
Pre Clinical Trials, Clinical Trials Stages 1 -4, CRO, Clinical Data, 5%
Fine Chemicals and Intermediates, 5%
Others, 6%
NEW
NEW
NEW
NEW
NEW